231 related articles for article (PubMed ID: 26411366)
1. USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2.
Li Z; Hao Q; Luo J; Xiong J; Zhang S; Wang T; Bai L; Wang W; Chen M; Wang W; Gu L; Lv K; Chen J
Oncogene; 2016 Jun; 35(22):2902-12. PubMed ID: 26411366
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration.
Xiao N; Li H; Luo J; Wang R; Chen H; Chen J; Wang P
Biochem J; 2012 Feb; 441(3):979-86. PubMed ID: 22029577
[TBL] [Abstract][Full Text] [Related]
3. USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation.
Fan YH; Yu Y; Mao RF; Tan XJ; Xu GF; Zhang H; Lu XB; Fu SB; Yang J
Cell Death Differ; 2011 Oct; 18(10):1547-60. PubMed ID: 21331078
[TBL] [Abstract][Full Text] [Related]
4. Mule determines the apoptotic response to HDAC inhibitors by targeted ubiquitination and destruction of HDAC2.
Zhang J; Kan S; Huang B; Hao Z; Mak TW; Zhong Q
Genes Dev; 2011 Dec; 25(24):2610-8. PubMed ID: 22016339
[TBL] [Abstract][Full Text] [Related]
5. Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth.
Wang Y; Zhang J; Wu L; Liu W; Wei G; Gong X; Liu Y; Ma Z; Ma F; Thiery JP; Chen L
Breast Cancer Res; 2018 Aug; 20(1):83. PubMed ID: 30071870
[TBL] [Abstract][Full Text] [Related]
6. Sumoylation of HDAC2 promotes NF-κB-dependent gene expression.
Wagner T; Kiweler N; Wolff K; Knauer SK; Brandl A; Hemmerich P; Dannenberg JH; Heinzel T; Schneider G; Krämer OH
Oncotarget; 2015 Mar; 6(9):7123-35. PubMed ID: 25704882
[TBL] [Abstract][Full Text] [Related]
7. USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1.
Zhang X; Berger FG; Yang J; Lu X
EMBO J; 2011 Jun; 30(11):2177-89. PubMed ID: 21522127
[TBL] [Abstract][Full Text] [Related]
8. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
Ashburner BP; Westerheide SD; Baldwin AS
Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889
[TBL] [Abstract][Full Text] [Related]
9. Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress.
Brandl A; Wagner T; Uhlig KM; Knauer SK; Stauber RH; Melchior F; Schneider G; Heinzel T; Krämer OH
J Mol Cell Biol; 2012 Oct; 4(5):284-93. PubMed ID: 22493095
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor alpha-induced nuclear factor kappaB activation via binding to and deubiquitinating receptor-interacting protein 1.
Xu G; Tan X; Wang H; Sun W; Shi Y; Burlingame S; Gu X; Cao G; Zhang T; Qin J; Yang J
J Biol Chem; 2010 Jan; 285(2):969-78. PubMed ID: 19910467
[TBL] [Abstract][Full Text] [Related]
11. Class I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells.
Schäfer C; Göder A; Beyer M; Kiweler N; Mahendrarajah N; Rauch A; Nikolova T; Stojanovic N; Wieczorek M; Reich TR; Tomicic MT; Linnebacher M; Sonnemann J; Dietrich S; Sellmer A; Mahboobi S; Heinzel T; Schneider G; Krämer OH
Cell Signal; 2017 Jan; 29():218-225. PubMed ID: 27838375
[TBL] [Abstract][Full Text] [Related]
12. Transforming Growth Factor β Inhibits MUC5AC Expression by Smad3/HDAC2 Complex Formation and NF-κB Deacetylation at K310 in NCI-H292 Cells.
Lee SU; Kim MO; Kang MJ; Oh ES; Ro H; Lee RW; Song YN; Jung S; Lee JW; Lee SY; Bae T; Hong ST; Kim TD
Mol Cells; 2021 Jan; 44(1):38-49. PubMed ID: 33510050
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis.
Xing C; Lu XX; Guo PD; Shen T; Zhang S; He XS; Gan WJ; Li XM; Wang JR; Zhao YY; Wu H; Li JM
Cancer Res; 2016 Jan; 76(1):83-95. PubMed ID: 26669864
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase 1 and 2 regulate Wnt and p53 pathways in the ureteric bud epithelium.
Chen S; Yao X; Li Y; Saifudeen Z; Bachvarov D; El-Dahr SS
Development; 2015 Mar; 142(6):1180-92. PubMed ID: 25758227
[TBL] [Abstract][Full Text] [Related]
15. The Deubiquitinating Enzyme USP4 Functions as an Oncoprotein in Gastric Cancer and Mediates NF-κB Signaling by Regulating PRL-3 Expression.
Tao Y; You W
Front Biosci (Landmark Ed); 2022 Oct; 27(10):286. PubMed ID: 36336860
[TBL] [Abstract][Full Text] [Related]
16. Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression.
Li P; Wang D; Yao H; Doret P; Hao G; Shen Q; Qiu H; Zhang X; Wang Y; Chen G; Wang Y
Oncogene; 2010 May; 29(21):3153-62. PubMed ID: 20190809
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity.
Harms KL; Chen X
Cancer Res; 2007 Apr; 67(7):3145-52. PubMed ID: 17409421
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase 2 is involved in DNA damage-mediated cell death of human osteosarcoma cells through stimulation of the ATM/p53 pathway.
Sun D; Yu M; Li Y; Xing H; Gao Y; Huang Z; Hao W; Lu K; Kong C; Shimozato O; Ozaki T; Zhu Y
FEBS Open Bio; 2019 Mar; 9(3):478-489. PubMed ID: 30868056
[TBL] [Abstract][Full Text] [Related]
19. HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins.
Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Xie HJ; Chang YG; Kim MG; Park H; Lee JY; Nam SW
J Cell Biochem; 2012 Jun; 113(6):2167-77. PubMed ID: 22492270
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis.
Wagner T; Brand P; Heinzel T; Krämer OH
Biochim Biophys Acta; 2014 Dec; 1846(2):524-38. PubMed ID: 25072962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
